Wellness Center USA Competitors

Wellness Center USA (OTCMKTS:WCUI) and Mateon Therapeutics (OTCMKTS:MATN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and price targets for Wellness Center USA and Mateon Therapeutics, as provided by MarketBeat.

Mateon Therapeutics has a consensus target price of $3.00, suggesting a potential upside of 971.43%. Given Mateon Therapeutics' higher possible upside, analysts plainly believe Mateon Therapeutics is more favorable than Wellness Center USA.

Insider & Institutional Ownership

0.1% of Wellness Center USA shares are owned by institutional investors. Comparatively, 0.0% of Mateon Therapeutics shares are owned by institutional investors. 14.1% of Wellness Center USA shares are owned by company insiders. Comparatively, 39.2% of Mateon Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Wellness Center USA and Mateon Therapeutics' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Wellness Center USA and Mateon Therapeutics' revenue, earnings per share (EPS) and valuation.

Wellness Center USA has higher revenue and earnings than Mateon Therapeutics.

Risk & Volatility

Wellness Center USA has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Mateon Therapeutics has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

Summary

Mateon Therapeutics beats Wellness Center USA on 5 of the 9 factors compared between the two stocks.

Wellness Center USA (OTCMKTS:WCUI) and Benitec Biopharma (NASDAQ:BNTC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Volatility and Risk

Wellness Center USA has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Benitec Biopharma has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Wellness Center USA and Benitec Biopharma, as reported by MarketBeat.

Benitec Biopharma has a consensus target price of $14.00, suggesting a potential upside of 168.71%. Given Benitec Biopharma's higher probable upside, analysts clearly believe Benitec Biopharma is more favorable than Wellness Center USA.

Institutional & Insider Ownership

0.1% of Wellness Center USA shares are held by institutional investors. Comparatively, 5.7% of Benitec Biopharma shares are held by institutional investors. 14.1% of Wellness Center USA shares are held by insiders. Comparatively, 1.0% of Benitec Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Wellness Center USA and Benitec Biopharma's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Wellness Center USA and Benitec Biopharma's revenue, earnings per share and valuation.

Wellness Center USA has higher earnings, but lower revenue than Benitec Biopharma.

Summary

Benitec Biopharma beats Wellness Center USA on 6 of the 8 factors compared between the two stocks.

Wellness Center USA (OTCMKTS:WCUI) and Mallinckrodt (OTCMKTS:MNKKQ) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Volatility and Risk

Wellness Center USA has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Mallinckrodt has a beta of 3.82, indicating that its share price is 282% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Wellness Center USA and Mallinckrodt, as reported by MarketBeat.

Institutional & Insider Ownership

0.1% of Wellness Center USA shares are held by institutional investors. Comparatively, 51.7% of Mallinckrodt shares are held by institutional investors. 14.1% of Wellness Center USA shares are held by insiders. Comparatively, 3.1% of Mallinckrodt shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Wellness Center USA and Mallinckrodt's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Wellness Center USA and Mallinckrodt's revenue, earnings per share and valuation.

Wellness Center USA has higher earnings, but lower revenue than Mallinckrodt.

Summary

Mallinckrodt beats Wellness Center USA on 5 of the 9 factors compared between the two stocks.

Wellness Center USA (OTCMKTS:WCUI) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Insider & Institutional Ownership

0.1% of Wellness Center USA shares are held by institutional investors. Comparatively, 8.9% of China SXT Pharmaceuticals shares are held by institutional investors. 14.1% of Wellness Center USA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for Wellness Center USA and China SXT Pharmaceuticals, as reported by MarketBeat.com.

Volatility & Risk

Wellness Center USA has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500.

Profitability

This table compares Wellness Center USA and China SXT Pharmaceuticals' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Wellness Center USA and China SXT Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Wellness Center USA has higher earnings, but lower revenue than China SXT Pharmaceuticals.

Summary

Wellness Center USA beats China SXT Pharmaceuticals on 4 of the 7 factors compared between the two stocks.

Wellness Center USA (OTCMKTS:WCUI) and Amarillo Biosciences (OTCMKTS:AMAR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Earnings and Valuation

This table compares Wellness Center USA and Amarillo Biosciences' gross revenue, earnings per share (EPS) and valuation.

Amarillo Biosciences has lower revenue, but higher earnings than Wellness Center USA.

Profitability

This table compares Wellness Center USA and Amarillo Biosciences' net margins, return on equity and return on assets.

Volatility & Risk

Wellness Center USA has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Amarillo Biosciences has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for Wellness Center USA and Amarillo Biosciences, as reported by MarketBeat.com.

Insider & Institutional Ownership

0.1% of Wellness Center USA shares are held by institutional investors. 14.1% of Wellness Center USA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Wellness Center USA beats Amarillo Biosciences on 5 of the 8 factors compared between the two stocks.

Wellness Center USA (OTCMKTS:WCUI) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Valuation and Earnings

This table compares Wellness Center USA and Millendo Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Wellness Center USA has higher revenue and earnings than Millendo Therapeutics.

Institutional & Insider Ownership

0.1% of Wellness Center USA shares are owned by institutional investors. Comparatively, 41.1% of Millendo Therapeutics shares are owned by institutional investors. 14.1% of Wellness Center USA shares are owned by company insiders. Comparatively, 3.7% of Millendo Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Wellness Center USA has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Millendo Therapeutics has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Profitability

This table compares Wellness Center USA and Millendo Therapeutics' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Wellness Center USA and Millendo Therapeutics, as provided by MarketBeat.com.

Millendo Therapeutics has a consensus price target of $3.80, indicating a potential upside of 251.85%. Given Millendo Therapeutics' higher probable upside, analysts plainly believe Millendo Therapeutics is more favorable than Wellness Center USA.

Summary

Millendo Therapeutics beats Wellness Center USA on 5 of the 9 factors compared between the two stocks.